TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.070
-0.020 (-0.96%)
Aug 5, 2026, 1:28 PM EDT - Market open
TuHURA Biosciences Employees
TuHURA Biosciences had 22 employees as of December 31, 2025. The number of employees increased by 3 or 15.79% compared to the previous year.
Employees
22
Change (1Y)
3
Growth (1Y)
15.79%
Revenue / Employee
n/a
Profits / Employee
-$1,406,025
Market Cap
131.82M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 22 | 3 | 15.79% |
| Dec 31, 2024 | 19 | 18 | 1,800.00% |
| Dec 31, 2023 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Nautilus Biotechnology | 127 |
| Connect Biopharma Holdings | 64 |
| PepGen | 59 |
| Genelux | 26 |
| Entera Bio | 22 |
| Unicycive Therapeutics | 22 |
| Spruce Biosciences | 14 |
HURA News
- 14 days ago - TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference - PRNewsWire
- 27 days ago - TuHURA Biosciences Proxy statement: Proxy filing - Filings
- 27 days ago - TuHURA Biosciences Proxy statement: Proxy filing - Filings
- 5 weeks ago - TuHURA Biosciences Proxy statement: Proxy filing - Filings
- 7 weeks ago - TuHURA Biosciences files IND application with FDA for study of TBS-2025 - TheFly
- 7 weeks ago - TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers - PRNewsWire
- 2 months ago - TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update - PRNewsWire
- 2 months ago - TuHURA Biosciences Earnings release: Q1 2026 - Filings